We are live on
!
Find out more
SC
Saturna Capital Portfolio holdings
AUM
$7.13B
1-Year Est. Return
35.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.53%
1 Year Est. Return
+35.47%
3 Year Est. Return
+92.6%
5 Year Est. Return
+130.56%
10 Year Est. Return
+515.97%
AUM
$5.16B
AUM Growth
+$514M
(+11%)
Cap. Flow
+$195M
Cap. Flow
% of AUM
3.78%
Top 10 Holdings %
Top 10 Hldgs %
37.6%
Holding
166
New
15
Increased
80
Reduced
28
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AutoZone
AZO
|
+$46.4M |
| 2 |
Idexx Laboratories
IDXX
|
+$35.9M |
| 3 |
Advanced Micro Devices
AMD
|
+$21.7M |
| 4 |
Merck
MRK
|
+$20.6M |
| 5 |
Microsoft
MSFT
|
+$20.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Parker-Hannifin
PH
|
+$13.3M |
| 2 |
AbbVie
ABBV
|
+$6.81M |
| 3 |
Eli Lilly
LLY
|
+$6.11M |
| 4 |
Apple
AAPL
|
+$2.94M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$1.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.99% |
| 2 | Healthcare | 25.28% |
| 3 | Industrials | 15.25% |
| 4 | Consumer Discretionary | 7.67% |
| 5 | Consumer Staples | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Freeport-McMoran
FCX
$86.8B
| $247K | ﹤0.01% |
6,037
| – | – |
|
152
Verizon
VZ
$202B
| $243K | ﹤0.01% |
6,260
+737
| +13% | +$29.1K |
|
|
ORAN
153
DELISTED
Orange
ORAN
| $239K | ﹤0.01% |
20,000
| – | – |
|
154
PepsiCo
PEP
$197B
| $228K | ﹤0.01% |
1,250
| – | – |
|
|
ZUO
155
DELISTED
Zuora, Inc.
ZUO
| $182K | ﹤0.01% |
+18,401
| New | +$154K |
|
156
Anavex Life Sciences
AVXL
$234M
| $154K | ﹤0.01% |
17,950
+5,650
| +46% | +$56.4K |
|
157
Iovance Biotherapeutics
IOVA
$2.07B
| $123K | ﹤0.01% |
+20,200
| New | +$139K |
|
158
Caribou Biosciences
CRBU
$146M
| $95.4K | ﹤0.01% |
+17,963
| New | +$112K |
|
159
Haleon
HLN
$45.3B
| $93.6K | ﹤0.01% |
11,500
| – | – |
|
|
DMTK
160
DELISTED
DermTech, Inc. Common Stock
DMTK
| $93K | ﹤0.01% |
+25,281
| New | +$106K |
|
161
Equinor
EQNR
$96.9B
| – | – |
-21,000
| Closed | -$752K |
|
162
Hasbro
HAS
$13.6B
| – | – |
-10,567
| Closed | -$645K |
|
163
Senseonics Holdings Inc
SENS
$257M
| – | – |
-671
| Closed | -$13.8K |
|
164
TotalEnergies
TTE
$193B
| – | – |
-23,800
| Closed | -$1.48M |
|
|
HZNP
165
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-17,325
| Closed | -$1.97M |
|
|
ATVI
166
DELISTED
Activision Blizzard
ATVI
| – | – |
-2,700
| Closed | -$207K |
|
Similar funds
FPA
TSC
MNA
UB
FPP
NAMA
CFG
LP
Saturna Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Saturna Capital held 166 positions worth $5.16B, up 11% from $4.65B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Saturna Capital deployed $195M of net new capital in Q1 2023, opening 15 new positions and adding to 80 existing holdings. Its largest new stake was AutoZone: 19,038 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Parker-Hannifin, an estimated $13.3M trimmed.
- Saturna Capital's largest Q1 2023 buy was AutoZone: 19,038 shares worth $46.8M.
- Saturna Capital added most to Advanced Micro Devices in Q1 2023, an estimated $21.7M increase.
- Saturna Capital's biggest Q1 2023 reduction was Parker-Hannifin, cutting an estimated $13.3M.
- Saturna Capital fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, selling an estimated $1.97M.
- Saturna Capital's ten largest holdings make up 38% of its $5.16B portfolio in Q1 2023.
- Saturna Capital opened 15 new positions and closed 6 in Q1 2023.
- Saturna Capital's portfolio value rose 11% quarter-over-quarter to $5.16B.
Based on Saturna Capital's 13F filing for Q1 2023, filed 15 May 2023.